Authors:
LUMMEN G
SPERLING H
BEX A
OTTO T
RUBBEN H
Citation: G. Lummen et al., MODERN CONCEPTS IN THE THERAPY OF URINARY-TRACT (KIDNEY, URETER, BLADDER AND PROSTATE) TUMORS, Pharmacological research, 38(3), 1998, pp. 151-164
Authors:
LUMMEN G
SPERLING H
LUBOLDT H
OTTO T
RUBBEN H
Citation: G. Lummen et al., PHASE-II TRIAL OF TITANOCENE DICHLORIDE IN ADVANCED RENAL-CELL CARCINOMA, Cancer chemotherapy and pharmacology, 42(5), 1998, pp. 415-417
Citation: H. Rubben, PRESELECTED BIOPSY FOR NORMAL-APPEARING MUCOSA OF SUPERFICIAL BLADDER-CARCINOMA - COMMENT, European urology, 34(5), 1998, pp. 409-410
Citation: S. Krege et al., PROSPECTIVE RANDOMIZED MULTICENTER PHASE-II STUDY FOR ADVANCED BLADDER-CANCER - CISPLATIN PLUS METHOTREXATE + - FACTOR AF2/, The Journal of urology, 159(5), 1998, pp. 637-637
Citation: M. Bohm et al., NEW PROGNOSTIC MARKER IN TRANSITIONAL-CELL CARCINOMA - DELETION AT THE DEL-27 TUMOR-SUPPRESSOR LOCUS ON 5P13-12 CORRELATES WITH TUMOR PROGRESSION, The Journal of urology, 159(5), 1998, pp. 1094-1094
Authors:
VIRCHOW S
ANSORGE N
RUBBEN H
SIFFERT G
SIFFERT W
Citation: S. Virchow et al., ENHANCED FMLP-STIMULATED CHEMOTAXIS IN HUMAN NEUTROPHILS FROM INDIVIDUALS CARRYING THE G-PROTEIN BETA-3 SUBUNIT-825 T-ALLELE, FEBS letters, 436(2), 1998, pp. 155-158
Authors:
LUMMEN G
SPERLING H
LUBOLDT H
OTTO T
RUBBEN H
Citation: G. Lummen et al., INTERFERON-ALPHA AND INTERFERON-GAMMA IN ADVANCED RENAL-CELL CARCINOMA - TREATMENT RESULTS, SURVIVAL, AND PROGNOSTIC FACTORS IN 81 PATIENTS, Onkologie, 20(6), 1997, pp. 466-471
Authors:
SCHUBERT J
SCHABEL J
HULAND H
RICHTERREICHHELM M
SCHALKHAUSER K
JOCHAM D
RUBBEN H
THUROFF J
Citation: J. Schubert et al., DIAGNOSIS AND TREATMENT STANDARDS IN KIDNEY-TRANSPLANTATION - SUMMARYFOR THE INTERNET, Der Urologe, 36(5), 1997, pp. 502-503
Authors:
OTTO T
KREGE S
GOEPEL M
BASCHEK R
RUBBEN H
Citation: T. Otto et al., LONG-TERM RESULTS OF OPERATIVE THERAPY FO R METASTASIZED NONSEMINOMATOUS GERM-CELL TUMORS (NSGT) IN ADVANCED TUMOR STAGES, Der Urologe, 36(4), 1997, pp. 339-342
Citation: T. Otto et al., 2ND-LINE CHEMOTHERAPY WITH MITOMYCIN-C AN D 5-FLUOROURACIL IN THE TREATMENT OF REFRACTORY METASTATIC CANCER OF THE URINARY-BLADDER, Der Urologe, 36(3), 1997, pp. 243-247
Citation: M. Goepel et al., LONG-TERM RESULTS OF WALLSTENT IMPLANTATI ON IN BENIGN PROSTATIC HYPERPLASIA AND IN HIGH-RISK GROUPS, Der Urologe, 36(2), 1997, pp. 151-156